OCS
Price:
$11.09
Market Cap:
$504.42M
Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which tar...[Read more]
Industry
Biotechnology
IPO Date
2021-05-18
Stock Exchange
NASDAQ
Ticker
OCS
According to Oculis Holding AG’s latest financial reports and current stock price. The company's current Current Ratio is 5.18. This represents a change of 2.73% compared to the average of 5.04 of the last 4 quarters.
The mean historical Current Ratio of Oculis Holding AG over the last ten years is 4.80. The current 5.18 Current Ratio has changed 10.68% with respect to the historical average. Over the past ten years (40 quarters), OCS's Current Ratio was at its highest in in the December 2021 quarter at 11.81. The Current Ratio was at its lowest in in the September 2021 quarter at 0.
Average
4.80
Median
3.83
Minimum
1.42
Maximum
11.81
Discovering the peaks and valleys of Oculis Holding AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 732.06%
Maximum Annual Current Ratio = 11.81
Minimum Annual Increase = -83.34%
Minimum Annual Current Ratio = 1.42
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.96 | 151.19% |
| 2024 | 2.37 | -55.19% |
| 2023 | 5.29 | 168.89% |
| 2022 | 1.97 | -83.34% |
| 2021 | 11.81 | 732.06% |
The current Current Ratio of Oculis Holding AG (OCS) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
4.54
5-year avg
5.48
10-year avg
4.80
Oculis Holding AG’s Current Ratio is less than Xencor, Inc. (6.57), greater than Kodiak Sciences Inc. (3.54), less than AnaptysBio, Inc. (7.58), greater than UroGen Pharma Ltd. (4.69), greater than Phathom Pharmaceuticals, Inc. (2.21), less than Nurix Therapeutics, Inc. (6.01), less than Nektar Therapeutics (10.21), greater than Sana Biotechnology, Inc. (1.29), less than BridgeBio Oncology Therapeutics Inc. (6.16), greater than Mind Medicine (MindMed) Inc. (4.69),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.57 | $914.17M | |
| 3.54 | $1.80B | |
| 7.58 | $2.42B | |
| 4.69 | $1.45B | |
| 2.21 | $827.07M | |
| 6.01 | $1.47B | |
| 10.21 | $1.16B | |
| 1.29 | $745.82M | |
| 6.16 | $620.83M | |
| 4.69 | $1.56B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oculis Holding AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oculis Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oculis Holding AG's Current Ratio?
How is the Current Ratio calculated for Oculis Holding AG (OCS)?
What is the highest Current Ratio for Oculis Holding AG (OCS)?
What is the 3-year average Current Ratio for Oculis Holding AG (OCS)?
What is the 5-year average Current Ratio for Oculis Holding AG (OCS)?
How does the current Current Ratio for Oculis Holding AG (OCS) compare to its historical average?